Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > BUSINESS
BUSINESS
- Takeda to Collaborate with 2 Universities on Application of Miniature Liver Technology to Drug Discovery Research
November 10, 2016
- Kipres AG’s Market Penetration Faster than Expected: Kyorin President
November 9, 2016
- Teva Takeda Pharma “Not a Threat” at Present: Nichi-Iko Pres. Tamura
November 9, 2016
- BIKEN, Mitsubishi Tanabe to Form Vaccine JV Next May
November 8, 2016
- Current Drug Pricing System Became Unfit for New Drugs Like Opdivo: Ono Chief
November 8, 2016
- Ono's Revenue and Profits Soar as Opdivo Sales Jump 1,714%
November 8, 2016
- MSD’s New Dual Oral Hep C Therapy to Challenge Harvoni; Effective Regardless of Resistance Mutations, Renal Impairment
November 8, 2016
- Japan Diabetes Market Likely to Grow 40% by 2024: Fuji Keizai
November 7, 2016
- Eisai’s Halaven Clinches NICE OK as 3rd-Line Breast Cancer Therapy
November 7, 2016
- Mitsubishi Tanabe to Offer Compound Library to Univ. of Tokyo
November 7, 2016
- Acne Med Epiduo Gel Hits Japan Shelves: Maruho
November 7, 2016
- JCR to Provide Temcell for IIT in Epidermolysis Bullosa
November 4, 2016
- Santen Profits Tumble Over 70% on Strong Yen, Divestment; Ophthalmology Biz Brisk
November 4, 2016
- Pfizer Japan Calls Off Transfer of Innovative Drugs after Global Split Plan Scrapped
November 4, 2016
- Mitsubishi Tanabe Licenses Cell Therapy Agent for Knee Osteoarthritis from S. Korean Firm
November 4, 2016
- Mitsubishi Tanabe Ekes Out Sales Rise on Simponi, Other Major Products
November 2, 2016
- Harvoni Top-Seller Drug in Japan in July-September: QuintilesIMS
November 2, 2016
- Strong Yen Dampens Sales of 4 Japanese Majors, but Global Brands Keep Up Momentum
November 2, 2016
- HER2-Targeting ADC Is One of Our Top Priorities: Daiichi Sankyo CEO
November 2, 2016
- Eisai’s Midterm Strategy Focusing on Neurology, Oncology “Gradually Producing Results”: CEO Naito
November 2, 2016
ページ
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s leading pharmaceutical wholesalers are bracing for a second consecutive year of profit declines, underscoring the growing challenge of generating…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…